Biomedical Catalyst 2025: Industry Led R&D Small and Large Projects

Innovate UK, part of UK Research and Innovation, will invest up to £25 million from the Innovate UK Biomedical Catalyst programme in innovation projects.

The aim of this industry-led research and development (R&D) competition is to support micro, small, and medium-sized enterprises (SMEs) to develop innovative solutions to address health, and healthcare, challenges.

This competition is split into two strands:

• “Biomedical Catalyst 2025: Industry led R&D small projects”: up to £500,000 in grant funding
• “Biomedical Catalyst 2025: Industry led R&D large projects”: more than £500,000 in grant funding

Your project can focus on any health, or healthcare, sector or discipline, including but not limited to:

• Advanced therapies (cell, gene, RNA, regenerative)
• Biosciences and platform technologies
• Preclinical tools, target discovery, and validation
• Therapeutics and medicine development, including antimicrobial resistance (AMR) and infectious disease
• Diagnostics and biomarkers, including AMR and infectious disease
• Medical technologies, devices, and robotics
• Precision and personalised medicine
• Digital and data-driven health
• Healthy ageing and independent living

Your project can include:

• Experimental evaluation (at laboratory scale)
• Use of in vitro and in vivo models to evaluate proof of concept or safety
• Exploring potential production mechanisms
• Prototyping
• Product development planning
• Intellectual property protection
• A demonstration of clinical utility and effectiveness
• A demonstration of safety and efficacy, including phase 1 and phase 2 clinical trials
• Regulatory planning